{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:36Z","timestamp":1781647056421,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical Key Disease Diagnosis and Treatment Technique Project of Suzhou","award":["LCZX202310"],"award-info":[{"award-number":["LCZX202310"]}]},{"name":"Soochow University Second Hospital Medical New Technology Special Assistance Plan Project","award":["23ZL002"],"award-info":[{"award-number":["23ZL002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor-associated macrophages (TAMs), a pivotal component of the tumor microenvironment (TME), play an important role in the development and progression of colorectal cancer (CRC). However, the function of macrophage-related genes (MRGs) in CRC remains poorly understood. This research examined the role of MRGs in CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MRGs were identified by integrating the gene set that exhibited differential expression between tumor and non-tumor tissues in CRC with the gene set associated with TAMs identified by CIBERSORT. To establish a prognostic signature specifically related to TAMs, a combination of univariate Cox regression and least absolute shrinkage operator analyses was utilized. By incorporating oncoPredict, Tumor Immune Dysfunction and Exclusion, mutation, cancer stem cell index, and metastasis data, we were able to predict various clinical features such as drug sensitivity, chemical sensitivity, and immunotherapeutic response. Furthermore, RNA extraction from CRC tissues enabled the validation of differential expression in prognostic MRGs using quantitative real-time polymerase chain reaction (qRT-PCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High TAM infiltration was positively associated with poor prognosis, and the macrophage-related gene (MRG) risk score showed a strong correlation with patient survival. The high-risk group demonstrates better immunotherapy response and six of the eight prognostic genes identified were associated with metastasis, suggesting that the high-risk group may be more susceptible to metastasis. The expression levels of two protective genes, MRPS7 and ORC1, were higher in normal tissues compared to tumor tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings could provide insights into the role of TAMs in predicting CRC prognosis and suggest potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15965-9","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:35:25Z","timestamp":1775464525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhuan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Long","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-You","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"1","key":"15965_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"15965_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA"},{"issue":"11","key":"15965_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"15965_CR4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jclinepi.2008.04.008","volume":"61","author":"DB Toll","year":"2008","unstructured":"Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61(11):1085\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.04.008.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"15965_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages [published correction appears in Nat Rev Clin Oncol. 2022]. Nat Rev Clin Oncol. 2022;19(6):402\u201321. https:\/\/doi.org\/10.1038\/s41571-022-00620-6.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"15965_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"15965_CR7","doi-asserted-by":"publisher","first-page":"34217","DOI":"10.18632\/oncotarget.9079","volume":"7","author":"J Mei","year":"2016","unstructured":"Mei J, Xiao Z, Guo C, et al. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget. 2016;7(23):34217\u201328. https:\/\/doi.org\/10.18632\/oncotarget.9079.","journal-title":"Oncotarget"},{"key":"15965_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2407-10-112","volume":"10","author":"J Ma","year":"2010","unstructured":"Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010;10:112. https:\/\/doi.org\/10.1186\/1471-2407-10-112. Published 2010 Mar 25.","journal-title":"BMC Cancer"},{"key":"15965_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2407-10-112","volume":"10","author":"J Ma","year":"2010","unstructured":"Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010;10:112. https:\/\/doi.org\/10.1186\/1471-2407-10-112. Published 2010 Mar 25.","journal-title":"BMC Cancer"},{"key":"15965_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev. 2017;114:206\u201321. https:\/\/doi.org\/10.1016\/j.addr.2017.04.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"15965_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1158\/1078-0432.CCR-16-0133","volume":"23","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies. Clin Cancer Res. 2017;23(4):876\u201384. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0133.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"15965_CR12","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"15965_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"5","key":"15965_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"13","key":"15965_CR15","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"15965_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, et al. M1\/M2 macrophages and their overlaps\u2013myth or reality?. Clin Sci. 2023;137(15):1067\u201393.","journal-title":"Clin Sci"},{"issue":"6","key":"15965_CR17","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"5","key":"15965_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R. Regularization Paths for Cox\u2019s Proportional Hazards Model via Coordinate Descent. J Stat Softw. 2011;39(5):1\u201313. https:\/\/doi.org\/10.18637\/jss.v039.i05.","journal-title":"J Stat Softw"},{"issue":"11","key":"15965_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"key":"15965_CR20","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-Associated Macrophages in Tumor Immunity [published correction appears in Front Immunol. 2021;12:775758]. Front Immunol. 2020;11:583084. https:\/\/doi.org\/10.3389\/fimmu.2020.583084. Published 2020 Dec 3.","journal-title":"Front Immunol"},{"issue":"6","key":"15965_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"15965_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.31050","volume":"72","author":"XL Liu","year":"2020","unstructured":"Liu XL, Pan Q, Cao HX, et al. Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor\/Akt\/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. Hepatology. 2020;72(2):454\u201369. https:\/\/doi.org\/10.1002\/hep.31050.","journal-title":"Hepatology"},{"issue":"1","key":"15965_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, et al. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. Cancer Discov. 2022;12(1):134\u201353. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0316.","journal-title":"Cancer Discov"},{"issue":"1","key":"15965_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","volume":"9","author":"JP V\u00e4yrynen","year":"2021","unstructured":"V\u00e4yrynen JP, Haruki K, Lau MC, et al. The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment. Cancer Immunol Res. 2021;9(1):8\u201319. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0527.","journal-title":"Cancer Immunol Res"},{"key":"15965_CR25","doi-asserted-by":"publisher","unstructured":"Zhao S, Mi Y, Guan B et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer [published correction appears in J Hematol Oncol. 2021;14(1):33]. J Hematol Oncol. 2020;13(1):156. Published 2020 Nov 19. https:\/\/doi.org\/10.1186\/s13045-020-00991-2","DOI":"10.1186\/s13045-020-00991-2"},{"issue":"1","key":"15965_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12967-023-04009-6","volume":"21","author":"J Zheng","year":"2023","unstructured":"Zheng J, Dou R, Zhang X, et al. LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages. J Transl Med. 2023;21(1):153. https:\/\/doi.org\/10.1186\/s12967-023-04009-6. Published 2023 Feb 25.","journal-title":"J Transl Med"},{"key":"15965_CR27","doi-asserted-by":"publisher","first-page":"103016","DOI":"10.1016\/j.redox.2023.103016","volume":"69","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhu L, Li X, et al. M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages. Redox Biol. 2023;69:103016.","journal-title":"Redox Biol"},{"key":"15965_CR28","doi-asserted-by":"publisher","unstructured":"Lv K, Zhang Y, Yin G et al. Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation. Exp Mol Med. 2025:1\u201314. https:\/\/doi.org\/10.1038\/s12276-025-01465-6.","DOI":"10.1038\/s12276-025-01465-6"},{"key":"15965_CR29","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, Zhu J, Lu S, et al. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J Controlled Release. 2025;382:113664.","journal-title":"J Controlled Release"},{"issue":"Suppl 8","key":"15965_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12864-018-5193-9","volume":"19","author":"J Martinez-Romero","year":"2018","unstructured":"Martinez-Romero J, Bueno-Fortes S, Mart\u00edn-Merino M, Ramirez de Molina A, De Las Rivas J. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling. BMC Genomics. 2018;19(Suppl 8):857. https:\/\/doi.org\/10.1186\/s12864-018-5193-9. Published 2018 Dec 11.","journal-title":"BMC Genomics"},{"issue":"3","key":"15965_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10120-022-01284-y","volume":"25","author":"S Umeda","year":"2022","unstructured":"Umeda S, Kanda M, Shimizu D, et al. Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells. Gastric Cancer. 2022;25(3):558\u201372. https:\/\/doi.org\/10.1007\/s10120-022-01284-y.","journal-title":"Gastric Cancer"},{"issue":"1","key":"15965_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71\u20138. https:\/\/doi.org\/10.1038\/nrc1256.","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"15965_CR33","doi-asserted-by":"publisher","first-page":"11063","DOI":"10.7150\/thno.45674","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Long X, Duan S, et al. CSRP2 suppresses colorectal cancer progression via p130Cas\/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways. Theranostics. 2020;10(24):11063\u201379. https:\/\/doi.org\/10.7150\/thno.45674. Published 2020 Sep 2.","journal-title":"Theranostics"},{"issue":"6","key":"15965_CR34","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.2353\/ajpath.2010.090663","volume":"176","author":"KG Claeys","year":"2010","unstructured":"Claeys KG, Sozanska M, Martin JJ, et al. DNAJB2 expression in normal and diseased human and mouse skeletal muscle. Am J Pathol. 2010;176(6):2901\u201310. https:\/\/doi.org\/10.2353\/ajpath.2010.090663.","journal-title":"Am J Pathol"},{"issue":"8","key":"15965_CR35","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/hmg\/ddu747","volume":"24","author":"MJ Menezes","year":"2015","unstructured":"Menezes MJ, Guo Y, Zhang J, et al. Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemia. Hum Mol Genet. 2015;24(8):2297\u2013307. https:\/\/doi.org\/10.1093\/hmg\/ddu747.","journal-title":"Hum Mol Genet"},{"issue":"22","key":"15965_CR36","doi-asserted-by":"publisher","first-page":"19363","DOI":"10.1074\/jbc.M100727200","volume":"276","author":"E Cavdar Koc","year":"2001","unstructured":"Cavdar Koc E, Burkhart W, Blackburn K, Moseley A, Spremulli LL. The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J Biol Chem. 2001;276(22):19363\u201374. https:\/\/doi.org\/10.1074\/jbc.M100727200.","journal-title":"J Biol Chem"},{"issue":"9","key":"15965_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.bbabio.2011.06.010","volume":"1807","author":"A R\u00f6tig","year":"2011","unstructured":"R\u00f6tig A. Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta. 2011;1807(9):1198\u2013205. https:\/\/doi.org\/10.1016\/j.bbabio.2011.06.010.","journal-title":"Biochim Biophys Acta"},{"key":"15965_CR38","doi-asserted-by":"publisher","unstructured":"De Ioannes P, Leon VA, Kuang Z et al. Structure and function of the Orc1 BAH-nucleosome complex. Nat Commun. 2019;10(1):2894. Published 2019 Jul 1. https:\/\/doi.org\/10.1038\/s41467-019-10609-y","DOI":"10.1038\/s41467-019-10609-y"},{"key":"15965_CR39","doi-asserted-by":"publisher","first-page":"1618471","DOI":"10.3389\/fmed.2025.1618471","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang K, Ning G. Constructing a novel mitochondrial metabolism-related genes signature to evaluate tumor immune microenvironment and predict survival of colorectal cancer. Front Med. 2025;12:1618471.","journal-title":"Front Med"},{"issue":"1","key":"15965_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-020-01720-w","volume":"39","author":"J Li","year":"2020","unstructured":"Li J, Hu M, Liu N, et al. HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p\/TGIF1\/TGF\u03b2 axis [published correction appears in J Exp Clin Cancer Res. 2021;40(1):404]. J Exp Clin Cancer Res. 2020;39(1):248. https:\/\/doi.org\/10.1186\/s13046-020-01720-w. Published 2020 Nov 17.","journal-title":"J Exp Clin Cancer Res"},{"key":"15965_CR41","doi-asserted-by":"publisher","first-page":"838006","DOI":"10.3389\/fmolb.2022.838006","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen P, Chen X, et al. ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer. Front Mol Biosci. 2022;9:838006. https:\/\/doi.org\/10.3389\/fmolb.2022.838006. Published 2022 Feb 9.","journal-title":"Front Mol Biosci"},{"issue":"186","key":"15965_CR42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.24976\/Discov.Med.202436186.126","volume":"36","author":"F Haumaier","year":"2024","unstructured":"Haumaier F, Dregelies T, Sterlacci W, et al. Methylation Analysis of Colitis-Associated Colorectal Carcinomas. Discov Med. 2024;36(186):1363\u20139.","journal-title":"Discov Med"},{"key":"15965_CR43","doi-asserted-by":"publisher","first-page":"109876","DOI":"10.1016\/j.cbi.2022.109876","volume":"357","author":"JR Mekala","year":"2022","unstructured":"Mekala JR, Ramalingam PS, Mathavan S, et al. Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC\/microRNA regulation. Chemico-Biol Interact. 2022;357:109876.","journal-title":"Chemico-Biol Interact"},{"key":"15965_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.25259\/Cytojournal_200_2024","volume":"22","author":"K Yu","year":"2025","unstructured":"Yu K, Yu Y, Zhang C, et al. Mechanistic insights into PDZK1-interacting protein 1 on the malignant progression of colorectal carcinoma. CytoJournal. 2025;22:52.","journal-title":"CytoJournal"},{"issue":"11","key":"15965_CR45","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.3390\/cancers12113463","volume":"12","author":"SF Wang","year":"2020","unstructured":"Wang SF, Huang KH, Tseng WC, et al. DNAJA3\/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells. Cancers (Basel). 2020;12(11):3463. https:\/\/doi.org\/10.3390\/cancers12113463. Published 2020 Nov 20.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"15965_CR46","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/gutjnl-2015-309193","volume":"65","author":"G Di Caro","year":"2016","unstructured":"Di Caro G, Cortese N, Castino GF, et al. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Gut. 2016;65(10):1710\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2015-309193.","journal-title":"Gut"},{"issue":"12","key":"15965_CR47","doi-asserted-by":"publisher","first-page":"e1342918","DOI":"10.1080\/2162402X.2017.1342918","volume":"6","author":"A Malesci","year":"2017","unstructured":"Malesci A, Bianchi P, Celesti G, et al. Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer. Oncoimmunology. 2017;6(12):e1342918. https:\/\/doi.org\/10.1080\/2162402X.2017.1342918. Published 2017 Jul 12.","journal-title":"Oncoimmunology"},{"issue":"11","key":"15965_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5.","journal-title":"Nat Rev Drug Discov"},{"key":"15965_CR49","doi-asserted-by":"crossref","unstructured":"Nittayaboon K, Leetanaporn K, Sangkhathat S et al. Proteomic Analysis of Butyrate-Resistant Colorectal Cancer-Derived Exosomes Reveals Potential Resistance to Anti-Cancer Drugs. Discovery medicine., 2024, 36(185): 1306\u201315.","DOI":"10.24976\/Discov.Med.202436185.121"},{"key":"15965_CR50","doi-asserted-by":"publisher","first-page":"1635449","DOI":"10.3389\/fphar.2025.1635449","volume":"16","author":"PS Ramalingam","year":"2025","unstructured":"Ramalingam PS, Chellasamy G, Hussain MS, et al. Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma. Front Pharmacol. 2025;16:1635449.","journal-title":"Front Pharmacol"},{"issue":"1","key":"15965_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"ZB Wang","year":"2024","unstructured":"Wang ZB, Zhang X, Fang C, et al. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy. Immunology. 2024;173(1):14\u201332.","journal-title":"Immunology"},{"key":"15965_CR52","doi-asserted-by":"publisher","first-page":"1383255","DOI":"10.3389\/fimmu.2024.1383255","volume":"15","author":"L Huang","year":"2024","unstructured":"Huang L, Tan J, Lin P, et al. Autoimmune encephalitis followed by hemophagocytic lymph histiocytosis: a case report. Front Immunol. 2024;15:1383255.","journal-title":"Front Immunol"},{"key":"15965_CR53","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","volume":"13","author":"G Tong","year":"2022","unstructured":"Tong G, Peng T, Chen Y, et al. Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol. 2022;13:901559.","journal-title":"Front Pharmacol"},{"issue":"12","key":"15965_CR54","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jvh.13886","volume":"30","author":"Q Ning","year":"2023","unstructured":"Ning Q, Yang T, Guo X, et al. CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. J Viral Hepatitis. 2023;30(12):951\u20138.","journal-title":"J Viral Hepatitis"},{"issue":"6","key":"15965_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16(6):361\u201375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"15965_CR56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.14744\/ejmo.2024.56068","volume":"8","author":"M Barahman","year":"2024","unstructured":"Barahman M, Alijanpour A, Naseri A, et al. Correlation between miR-27 rs895819 and miR-423 rs6505162 Polymorphisms and Susceptibility to Colorectal Cancer in the Iranian Population: A Case-Control Study. Eurasian J Med Oncol. 2024;8(3):348\u201357.","journal-title":"Eurasian J Med Oncol"},{"key":"15965_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3389\/fbioe.2020.00817","volume":"8","author":"B He","year":"2020","unstructured":"He B, Zhu R, Yang H, et al. Assessing the impact of data preprocessing on analyzing next generation sequencing data. Front Bioeng Biotechnol. 2020;8:817.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"15965_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217.","journal-title":"Nat Rev Clin Oncol"},{"key":"15965_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2015.12.007","volume":"39","author":"F Garrido","year":"2016","unstructured":"Garrido F, Aptsiauri N, Doorduijn EM, Garcia Lora AM, van Hall T. The urgent need to recover MHC class I in cancers for effective immunotherapy. Curr Opin Immunol. 2016;39:44\u201351. https:\/\/doi.org\/10.1016\/j.coi.2015.12.007.","journal-title":"Curr Opin Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15965-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:31:44Z","timestamp":1781645504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15965-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15965"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15965-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Second Affiliated Hospital of Soochow University granted authorization for this study. The study adhered to the principles outlined in the 1964 Helsinki Declaration and its subsequent amendments for ethical research involving human subjects. Informed consent to participate was obtained from all patients and\/or their legally authorized representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"635"}}